Most traditional appetite suppressants act on one neurotransmitter pathway; typically dopamine or serotonin alone. Tesofensine inhibits the reuptake of all three primary monoamine neurotransmitters simultaneously.
This triple mechanism produces appetite suppression through multiple neurological pathways at once; coupled with increased satiety signaling and elevated metabolic rate through norepinephrine's adrenergic activity. The combined effect is more comprehensive appetite and metabolic regulation than single-pathway approaches can achieve.